Fibryga is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is .
Product ID | 68982-347_0bdefd2a-8e03-2f0f-b075-c3b2b1574807 |
NDC | 68982-347 |
Product Type | Plasma Derivative |
Proprietary Name | Fibryga |
Generic Name | Fibrinogen (human) |
Dosage Form | Kit |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-10-16 |
Marketing Category | BLA / BLA |
Application Number | BLA125612 |
Labeler Name | Octapharma USA Inc |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2017-10-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125612 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2017-10-16 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FIBRYGA 87466024 5364628 Live/Registered |
Octapharma AG 2017-05-26 |